DJIA 16,501.65 -12.72 -0.08%
NASDAQ 4,126.97 0.00 0.00%
S&P 500 1,875.39 -4.16 -0.22%
market minute promo

1.60 -0.15 (-8.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LXRX $1.60 -8.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.73
Previous Close $1.75
Daily Range $1.58 - $1.74
52-Week Range $1.39 - $3.18
Market Cap $822.1M
P/E Ratio -8.75
Dividend (Yield) $0.00 (0.0%)
Volume 1,620,993
Average Daily Volume 1,634,505
Current FY EPS -$0.16

Sector

Healthcare

Industry

Drugs

Lexicon Pharmaceuticals, Inc. (LXRX) Description

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Website: http://www.lexicon-genetics.com/

News & Commentary

Lexicon Pharma to Cut Around 45% of Workforce; CEO to Depart

Lexicon Pharmaceuticals will focus its efforts on late-stage drug development, which will lead to the loss of 115 jobs.

Encouraging Results from Lexicon Candidate - Analyst Blog

More Positive News For Lexicon, But Not The Big Announcement

Lexicon Pharmaceuticals' CEO Discusses LX4211 Positive Results in Type 1 Diabetes Clinical Trial (Tr

Lexicon Pharmaceuticals' CEO Discusses LX4211 Positive Results in Type 1 Diabetes Clinical Trial (Transcript)

Mid-Morning Market Update: Markets Open Higher; Citigroup Results Beat Estimates

Mid-Morning Market Update: Markets Open Higher; Citigroup Results Beat Estimates

Morning Market Movers

Sector Update: Healthcares Flat to Lower Pre-Market; Lexicon Soars 20% on Study of Diabetes Treatmen

Sector Update: Healthcares Flat to Lower Pre-Market; Lexicon Soars 20% on Study of Diabetes Treatment

Lexicon Pharmaceuticals up 25% on drug trial

Lexicon Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript

5 Stocks Under $10 Set to Soar

See More LXRX News...

LXRX's Top Competitors

LXRX $1.60 (-8.57%)
Current stock: LXRX
AMGN $113.32 (-5.02%)
Current stock: AMGN
GILD $73.86 (1.37%)
Current stock: GILD
BIIB $306.75 (0.18%)
Current stock: BIIB